Plasma protein binding

Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine

Retrieved on: 
Wednesday, November 1, 2023
Plasma protein binding, Heart failure with preserved ejection fraction, PALO, Cell, IPS, GMP, Regenerative medicine, Patient, Heart failure, Cardiospermum, Peace, Pharmaceutical industry, Vaccine

This achievement marks a significant step forward in the realization of autologous cardiac regenerative medicine with I Peace's personal iPS cell banking service (My Peace), to manufacture and store iPS cells, and induce them into cardiomyocytes for use in autologous cell therapy.

Key Points: 
  • This achievement marks a significant step forward in the realization of autologous cardiac regenerative medicine with I Peace's personal iPS cell banking service (My Peace), to manufacture and store iPS cells, and induce them into cardiomyocytes for use in autologous cell therapy.
  • A major advantage of medical treatment using autologous iPS cells is that immunosuppressive agents are not necessary because no immune reaction occurs when cells are transplanted.
  • However, the differentiation efficiency of iPS cells into target cells varies, and to efficiently produce cardiomyocytes from different donor-derived iPS cells, it is necessary to optimize the method of cardiomyocyte production for each iPS cell.
  • I Peace will continue to work together with Heartseed towards establishing regenerative medicine for heart failures using patients' own iPS cells.

Liberty HealthShare Launches Catastrophic Sharing Program

Retrieved on: 
Wednesday, November 1, 2023
Insurance, Policy, Freedom, Medicare Part D, Plasma protein binding, Liberty, Dental care, Multimedia, HealthShare, Transport, ValloCycle Bike-Share Program, Shipbuilding, Life insurance, Health insurance, LASIK

CANTON, Ohio, Nov. 1, 2023 /PRNewswire/ -- Liberty HealthShare®, one of the country's leading Christian healthsharing ministries, today launched a new catastrophic sharing program designed specifically for young adults.

Key Points: 
  • CANTON, Ohio, Nov. 1, 2023 /PRNewswire/ -- Liberty HealthShare®, one of the country's leading Christian healthsharing ministries, today launched a new catastrophic sharing program designed specifically for young adults.
  • Liberty HealthShare today launched Liberty Freedom, a new catastrophic sharing program designed for young adults.
  • In addition to Liberty Freedom, Liberty HealthShare has a variety of sharing programs from which to choose.
  • The three core Liberty HealthShare sharing programs, Liberty Unite, Liberty Connect, and Liberty Essential, are excellent for singles, couples, and families.

South Rampart Pharma Expands Global Patent Portfolio with EU Approval for FDA Fast-Tracked SRP-001 for Pain

Retrieved on: 
Wednesday, November 1, 2023
Female, FDA, White Light Rock & Roll Review, Aes, Patent, Neuropathic pain, Wireless ambulatory ECG, U.S. Patent No. 1, Fast Track, Liver, MAD, Kidney, EPO, Volunteering, Priority review, Male, NSAIDS, Unified Patent Court, European Patent Office, PK, Accelerated approval (FDA), New Drug Application, Pain, Liver failure, Nonsteroidal anti-inflammatory drug, OBI Pharma, Inc., NDA, Fast track (FDA), Safety, Vital signs, Paracetamol, European Patent Convention, Plasma protein binding, Pharmaceutical industry, EU

NEW ORLEANS, Nov. 1, 2023 /PRNewswire/ -- South Rampart Pharma, Inc. ("South Rampart" or the "Company"), a clinical-stage life science company focused on developing innovative pain treatments, announced today the issuance of European Patent No. 3672938 by the European Patent Office (EPO) effective November 1, 2023. This patent will apply to all Unified Patent Court-participating and non-participating European Unitary member states.

Key Points: 
  • This patent will apply to all Unified Patent Court-participating and non-participating European Unitary member states.
  • This patent, excluding possible patent term extensions, is expected to provide South Rampart with market exclusivity in the EPO member states until 2038, aligning with the U.S. Patent No.
  • On October 4, 2023, the U.S. FDA granted Fast Track designation to SRP-001 for acute pain.
  • The FDA Fast Track designation allows for more frequent interactions with the FDA, streamlining the clinical development plan and trial design to expedite drug approval.

Public Advisory - Buying your health products on the Internet? Know the risks

Retrieved on: 
Tuesday, October 31, 2023
Sale, The Royal Canadian Mounted Police in Quebec, Health Canada, Health, Homeopathy, Plasma protein binding, Canada Border Services Agency, NPN, DIN, Internet, CBSA, Partnership, Pharmacy, INTERPOL, Hormone, Safety, Drug identification number, Natural product, Medical device, Dietary supplement

Drugs, natural health products, and medical devices that have not been authorized by Health Canada and may pose serious health risks.

Key Points: 
  • Drugs, natural health products, and medical devices that have not been authorized by Health Canada and may pose serious health risks.
  • It is important to know how to spot risky websites and products if you are buying health products—including drugs, natural health products, and medical devices—online.
  • Unauthorized health products have not been assessed by Health Canada for safety, efficacy, and quality and as a result, can pose serious risks to your health.
  • Report adverse events or complaints involving drugs, natural health products or medical devices, including illegal health products, to Health Canada.

Stride Health Kicks Off 2024 ACA Open Enrollment with New Plan Selection Experience and New Partners

Retrieved on: 
Friday, October 27, 2023
Insurance, ACA, DoorDash, Tax, Health, Plasma protein binding, Activity, Uber, Stride Health, Prescription, Instacart, Safety, Amazon, Blog, Mobile phone, Health insurance, Satellite navigation device, Online shopping, Apple, Stride

SAN FRANCISCO, Oct. 27, 2023 /PRNewswire/ -- Stride Health, the leader in portable benefits technology, is heading into the 2024 Open Enrollment period with a new personalized plan selection experience for consumers, major upgrades to its app, which helps self-employed individuals save money on taxes and benefits, and several new partnerships. These new product enhancements and partnerships are key to helping independent workers in all 50 states better navigate their health insurance options during this critical time of year.  

Key Points: 
  • Stride heading into Open Enrollment period with a new plan selection experience, upgrades to app, and new partnerships.
  • "We're excited to kick off Open Enrollment this year with an overhauled enrollment experience designed to give our members faster personalized guidance, and to welcome a slew of new partners using Stride to help get more Americans covered for 2024," said Noah Lang, Co-founder and CEO of Stride Health.
  • "Stride was founded on the principle that everyone, no matter what type of work they do, should have easy access to affordable healthcare coverage.
  • For more information on 2024 Open Enrollment at Stride, please visit our blog here .

Harris Teeter to host drug take-back event on Oct. 28 at four store locations

Retrieved on: 
Friday, October 27, 2023
Substance Abuse and Mental Health Services Administration, Third Eye Shoppe, SAFE, Family, Plasma protein binding, DEA, Psychological abuse, Friends, National Survey on Drug Use and Health, Partnership, Mental health service, Substance Abuse, Davis Lake, Pharmaceutical industry, Health

MATTHEWS, N.C., Oct. 27, 2023 /PRNewswire-PRWeb/ -- Harris Teeter will host a drug take-back event at four of its Charlotte locations from 10 a.m. – 2 p.m. on Saturday, Oct. 28, 2023 , as part of the U.S. Drug Enforcement Administration's National Prescription Drug Take-Back Day. These events will provide a safe, convenient and anonymous way for local residents to dispose of unused or expired medications.

Key Points: 
  • MATTHEWS, N.C., Oct. 27, 2023 /PRNewswire-PRWeb/ -- Harris Teeter will host a drug take-back event at four of its Charlotte locations from 10 a.m. – 2 p.m. on Saturday, Oct. 28, 2023 , as part of the U.S. Drug Enforcement Administration's National Prescription Drug Take-Back Day.
  • These events will provide a safe, convenient and anonymous way for local residents to dispose of unused or expired medications.
  • The goal is to help the police department keep medications off the street by proper disposal of prescription medications, and knowing the dangers associated with drug abuse.
  • You can find more information about Harris Teeter's commitment to drug disposal solutions on our website.

Two Day Online Development of Combination Pharma Products Training Course: Focus on Critical Interactions - Navigating GMP and Quality in Pharma (February 12-13, 2024) - ResearchAndMarkets.com

Retrieved on: 
Friday, October 27, 2023
Training, Education, Combination, Good manufacturing practice, GMP, European, CTD, Research, R, Common Technical Document, Plasma protein binding, Medical device, EU

The "Development of Combination Products: Critical Interactions Training Course" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Development of Combination Products: Critical Interactions Training Course" conference has been added to ResearchAndMarkets.com's offering.
  • This program provides valuable insights into crafting an effective regulatory strategy while addressing crucial aspects of Good Manufacturing Practices (GMP) and quality processes.
  • Our interactive seminar serves as a guide to understanding both the European Union (EU) and US approaches to handling drug/device and device/drug combination products.
  • Furthermore, this seminar will emphasize the interconnectedness of quality, regulatory affairs, research and development (R&D), and production functions.

Peggy Van De Plassche to Share Insights on "The Microdose Diet" at Wonderland Conference in Miami

Retrieved on: 
Thursday, October 26, 2023
Microdosing, Consciousness, Health, Conference, New Wave, Benefit, Emotion, Pleasure, Plasma protein binding, Brain, Success, Happiness, Longevity, Mental health, Pharmaceutical industry, Amazon

Toronto, Ontario--(Newsfile Corp. - October 26, 2023) - Peggy Van de Plassche, an esteemed expert in health and wellness, is set to share her innovative perspective on "The Microdose Diet" at the highly anticipated Wonderland Conference in Miami.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - October 26, 2023) - Peggy Van de Plassche, an esteemed expert in health and wellness, is set to share her innovative perspective on "The Microdose Diet" at the highly anticipated Wonderland Conference in Miami.
  • Ms. Van de Plassche, a renowned entrepreneur, author, speaker and advocate for alternative medicine, will be one of the distinguished speakers featured at the conference.
  • The Microdose Diet, a groundbreaking concept introduced by Peggy Van de Plassche, explores the benefits of combining alternative medicine in a 90 day protocol.
  • "I am thrilled to join thought leaders in discussing the tremendous value of psychedelic medicine on mental health and longevity at the Wonderland Conference.

Bioxytran Gets Broad Patent Coverage on 60+ Viruses

Retrieved on: 
Tuesday, October 24, 2023
RSV, Patent, Epstein–Barr virus, Viral, HAART, Reading, Lectin, Nipa, Hepatitis C, Measles, Protease, Pathology, HIV, Intellectual property, Virus, Cell, Research, Drug development, COVID-19, Mumps, MOA, Virology, Rubella, Simplex, Shingles, Drug resistance, Movement, Enzyme inhibitor, Plasma protein binding, DNA, Vaccine, Pharmaceutical industry, H1N1, Galectin

BOSTON, MASSACHUSETTS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral diseases, announced that the U.S Patent and Trademark Office (USPTO) has published the Company’s patent application WO2023178228A1 Lectin-binding carbohydrates for treating viral infections. The pending patent covers broad claims about the use of hundreds of combinations of antiviral complex carbohydrate drugs to treat over 60 named viruses.

Key Points: 
  • The pending patent covers broad claims about the use of hundreds of combinations of antiviral complex carbohydrate drugs to treat over 60 named viruses.
  • This patent represents what we believe is a new direction in the evolution of antiviral therapies that originally started during the HIV epidemic.
  • This pending patent with its broad claims also shows the Company is well-positioned with respect to its intellectual property portfolio.
  • This patent covers some of the largest indications in virology and includes viruses like COVID-19, influenza, herpes, Epstein-Barr, shingles, hepatitis C, measles, mumps, and rubella.

New EO Care Survey of 1000+ Finds 18 Percent of Americans Use Cannabis for Health Reasons Today, but 65 Percent Would Use If Guided by a Clinician

Retrieved on: 
Tuesday, October 24, 2023
Knowledge, Cannabis, Neuropathic pain, Plasma protein binding, Workplace, Nausea, Epilepsy, Sleep, Drug, Anxiety, Pain, Appetite, Nursing

All respondents were employed at least part-time and were from US states where cannabis is legal for medical and/or recreational use.

Key Points: 
  • All respondents were employed at least part-time and were from US states where cannabis is legal for medical and/or recreational use.
  • 18 percent of respondents have used cannabis for health reasons in the past year, 19 percent have used cannabis for recreational reasons, and 14 percent have used it for both.
  • 51 percent said they would be likely/very likely to use cannabis if it were offered by their health plan.
  • 65 percent of respondents said they would feel more comfortable using cannabis if it were screened and dosed by a clinician.